Columbus, OHNCT07377747Now EnrollingIRB Ready

Retroperitoneal Liposarcoma Clinical Trial in Columbus, OH

Access cutting-edge retroperitoneal liposarcoma treatment through this clinical trial at a research site in Columbus. Study-provided care at no cost to qualified participants.

Sponsored by Australia and New Zealand Sarcoma Association

Quick Self-Assessment

See if you qualify for this Columbus location

Preparing your pre-screening questions…

Expert Care in Columbus

Access retroperitoneal liposarcoma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related retroperitoneal liposarcoma treatment provided free

Apply for This Columbus Location

Check if you qualify for this retroperitoneal liposarcoma clinical trial in Columbus, OH

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Columbus

    Convenient for OH residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Columbus site if eligible
  4. 4Begin participation

About This Retroperitoneal Liposarcoma Study in Columbus

The aim of the study is to collect prospective data on the treatment outcomes in patients with first localized, resectable recurrent retroperitoneal well-differentiated and/or dedifferentiated liposarcoma undergoing curative intent treatment. Patients enrolled in this study will form a validation cohort of the TARPSWG recurrent RPS nomogram. The treatment decision (surgery alone, or preoperative RT +/- chemotherapy followed by surgery) is per the institutional multidisciplinary team recommendation.

Sponsor: Australia and New Zealand Sarcoma Association

Who Can Participate

Inclusion Criteria

Adult age ≥ 18 presenting with first recurrent well-differentiated and/or dedifferentiated liposarcoma of retroperitoneal space or pelvis after previous macroscopically complete resection (R0/R1 resection)
No distant metastasis on cross-sectional imaging of chest/abdomen/pelvis (CT and/or MRI) within 1 month to confirm the absence of metastatic disease
Previous histologically proven well-differentiated or dedifferentiated liposarcoma histology only
Sarcoma not originating from bone or abdominal or gynecological viscera
Tumor confirmed to be resectable with likely R0/R1 resection, and all disease must be deemed to be treatable by RT (joint decision by surgeon and radiation oncologist at a sarcoma multidisciplinary team meeting)
WHO performance status 0-2
American Society of Anaesthesiologist (ASA) score 1-3
No prior RT for the retroperitoneal liposarcoma
Prior systemic therapy is allowed
No concurrent active malignancy (except for low risk skin malignancy, low risk prostate carcinoma, low risk breast carcinoma including in situ disease)
Women of childbearing potential must have a negative pregnancy test within 3 weeks prior to the first day of study treatment
Patient deemed able to comply with study requirements according to investigator evaluation
Signed, IRB-approved written informed consent

Exclusion Criteria

Unresectable disease or likely R2 resection as assessed by the multidisciplinary sarcoma team
Extent of recurrence where preoperative RT to all visible disease is not deemed to be feasible
Contradiction for RT such as history of bowel obstruction or mesenteric ischemia or severe chronic inflammatory bowel disease
Myxoid liposarcoma histology

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Columbus?

Yes, this clinical trial (NCT07377747) has an active research site in Columbus, OH that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Retroperitoneal Liposarcoma Treatment Options in Columbus, OH

If you're searching for retroperitoneal liposarcoma treatment options in Columbus, OH, this clinical trial (NCT07377747) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Columbus research site is actively enrolling participants for this clinical trial. You'll receive care from experienced retroperitoneal liposarcoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all retroperitoneal liposarcoma clinical trials near you to find additional studies recruiting in your area.

More Sarcoma Trials in Columbus, OH

See all sarcoma clinical trials recruiting in Columbus — not just this study.

Browse Sarcoma Trials in Columbus →

Browse More Trials by Condition

Sarcoma TrialsPulmonary Embolism TrialsEssential Tremor TrialsSleep Apnea TrialsSarcoma Soft Tissue TrialsAll Conditions →

Ready to Join in Columbus?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Columbus, OH